NCT03830710View on ClinicalTrials.gov

8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

December 1, 2018

Conditions
Premalignant Lesion
Trial Locations (1)

Unknown

Sandy hassan shaaban, Cairo

All Listed Sponsors
lead

Fayoum University

OTHER

NCT03830710 - 8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions | Biotech Hunter | Biotech Hunter